Pilot Randomized Trial of Tissue Plasminogen Activator in Acute Ischemic Stroke
Stroke 24:1000-1004, Haley,E.C.,et al, 1993
Evolving Toward Effective Therapy for Acute Ischemic Stroke
JAMA 270:360-364, Fisher,M.&Bogousslavsky,J., 1993
Vaccine-Associated Paralytic Poliomyelitis
NEJM 329:810-811, Mermel,L.,et al, 1993
Persistence of Initial Infection in Recurrent Cryptococcus Neuformans Meningitis
Lancet 341:595-596, Spitzer,E.D.,et al, 1993
Direct Diagnosis of Myotonic Dystrophy with a Disease-Specific DNA Marker
NEJM 328:471-475, Shelbourne,P.,et al, 1993
Provocation paralysis
Editorial, Lancet 340:1005-10061992., , 1992
The Postpolio Syndrome:No Evidence for Poliovirus Persistence
Ann Neurol 32:728-732, Melchers,W.,et al, 1992
Early Computed Tomographic Findings for Thrombolytic Therapy in Patients with Acute Brain Embolism
Stroke 23:20-23, Okada,Y.,et al, 1992
The Risk of Stroke in Patients with Acute Myocardial Infarction after Thrombolytic and Antithrombotic Treatment
NEJM 327:1-6, Maggioni,A.P.,et al, 1992
Intrinsic Spinal Cord Haemorrhage Due to Streptokinase Treatment for Myocardial Infarction
JNNP 55:740, Cruickshank,G.S.,et al, 1992
Urgent Therapy for Stroke Part II, Pilot Study of Tissue Plasminogen Activator Administered 91-180 Minutes from Onset
Stroke 23:641-645, Haley,E.C.,et al, 1992
Urgent Therapy for Stroke Part I, Pilot Study of Tissue Plasminogen Activator Administered within 90 Minutes
Stroke 23:632-640, Brott,T.G.,et al, 1992
Intravenous Recombinant Tissue Plasminogen Activator in Acute Carotid Artery Territory Stroke
Neurol 42:976-982, Mori,E.,et al, 1992
Safety & Efficacy of Intravenous Tissue Plasminogen Activator & Heparin in Acute Middle Cerebral Artery Stroke
Stroke 23:646-652, vonKummer,R.&Hacke,W., 1992
Intracranial Hemorrhage After Coronoary Thrombolysis with Tissue Plsminogen Activator
Am J Med 92:384-390, Kase,C.S.,et al, 1992
Recombinant Tissue Plasminogen Activator in Acute Thrombotic and Embolic Stroke
Ann Neurol 32:78-86, delZoppo,G.J.,et al, 1992
The First Decade of Molecular Genetics in Neurology:Changing Clinical Thought and Practice
Ann Neurol 32:207-214, Rowland,L.P., 1992
Ataxia-Telangiectasia in a Child with Vaccine-Associated Paralytic Poliomyelitis
J Pediatr 121:405-407, Pohl,K.R.E.,et al, 1992
De-Novo Mutation in Hereditary Motor and Sensory Neuropathy Type I
Lancet 339:1081-1082, Hoogendijk,J.E.,et al, 1992
Syringomyelia as a Late Complication of Paralytic Poliomyelitis
Neurol 42:1421-1422, Feve,A.,et al, 1992
Stroke Complic Acute MI, A Meta-Analysis of Risk Modific by Antigoac & Thrombolytic Therapy
Arch Int Med 152:2020-2024, Viatkus,P.T.,et al, 1992
Screening for von Hippel-Lindau Disease by DNA Polymorphism Analysis
JAMA 267:1226-1231, Glenn,G.M.,et al, 1992
Thrombolysis in Acute Ischemic Stroke:Does it Work
Stroke 23:1826-1839, Wardlaw,J.M.&Warlow,C.P., 1992
Acute Paralytic Poliomyelitis Presenting as Guillain-Barre Syndrome
J Infection 22:129-133, Yohannan,M.D.,et al, 1991
Antithrombotic Therapy in Cerebrovascular Disease
Ann Int Med 115:885-895, Rothrock,J.F.&Hart,R.G., 1991
CT patterns of Intracranial Hemorrhage Complicating Thrombolytic Therapy for Acute Myocardial Infarction
Radiology 181:555-559, Uglietta,J.P.,et al, 1991
Intracerebral Hemorrhage Related to Cerebral Amyloid Angiopathy and t-PA Treatment
Ann Neurol 29:210-213, Pendlebury,W.W.,et al, 1991
Recombinant Human Erythropoietin and Renal Anemia:Molecular Biology, Clinical Efficacy, and Nervous System Effects
Ann Int Med 114:402-416, Nissenson,A.R.,et al, 1991
Intracerebral Hemorrhage
Stroke 22:684-691, Feldmann,E., 1991
Cerebrovascular Events After Myocardial Infarction:Analysis of the GISSI Trial
BMJ 302:1428-1431, Maggioni,A.P.,et al, 1991
Intrathecal Immune Response in Patients with the Post-Polio Syndrome
NEJM 325:749-755, Sharief,M.K.,et al, 1991
Late Effects of Paralytic Poliomyelitis in Olmsted County, Minnesota
Neurol 41:501-507, Windebank,A.J.,et al, 1991
Dysphagia in Patients with the Post-Polio Syndrome
NEJM 324:1162-1167, 1206-12071991., Sonies,B.C.&Dalakas,M.C., 1991
Erythropoeitin and Visual Hallucinations
NEJM 325:285, Steinberg,H., 1991
Tissue Plasminogen Activator Plus Glutamate Antagonist Improves Outcome after Embolic Stroke
Arch Neurol 48:1235-1238, Zivin,J.A.&Mazzarella,V., 1991
Dysphagia in the Post-Polio Syndrome
Letters, NEJM 325:1107-11081991., , 1991
Changes in Middle Cerebral Artery Blood Velocity in Uremic Patients after Hemodialysis
Stroke 22:1508-1511, Postiglione,A.,et al, 1991
Direct Diagnosis by DNA Analysis of the Fragile X Syndrome of Mental Retardation
NEJM 325:1673-1681, Rousseau,F.,et al, 1991
Prenatal Diagnosis of Fragile X Syndrome by Direct Detection of the Unstable DNA Sequence
NEJM 325:1720-1738, Sutherland,G.R.,et al, 1991
Guillain-Barre Syndrome After Streptokinase Therapy
Acta Neurologica Scand 82:153, Roquer,J.,et al, 1990
Cytomegalovirus and Rasmussen's Encephalitis
Lancet 336:1282-1284, Power,C.,et al, 1990
What Causes Motoneuron Disease?
Editorial, Lancet 336:1033-10351990., , 1990
Genetic Testing for Huntington's Disease
BMJ 300:1089-1090, Harper,P.,et al, 1990
AIDS-Assoc Progressive Multifocal Leukoencephalopathy (PML) :Comparison to Non-AIDS PML
Neurol 40:1073-1078, Aksamit,A.J.,et al, 1990
Molecular Genetics of Duchenne and Becker Muscular Dystrophy
J Pediatr 117:1-15, Darras,B.T., 1990
Vaccine-Associated Paralytic Poliomyelitis, Regional Case Series and Review
Arch Neurol 47:541-544, Querfurth,H.&Swanson,P.D., 1990
Poliomyelitis Outbreak in Isreal in 1988:A Report with two Commentaries
Lancet 335:1192-1198, Slater,P.E.,et al, 1990
Ancrod Causes Rapid Thrombolysis in Patients with Acute Stroke
Am J Med Sci 299:319-325, Polla,K.V.E.,et al, 1990
Reptured Arteriovenous Malformation Complicating Thrombolytic Therapy with Tissue Plasminogen Activator
Arch Neurol 47:105-106, Proner,J.,et al, 1990
Intracranial Hemorrhage After Use of Tissue Plasminogen Activator for Coronary Thrombilysis
Ann Int Med 112:17-21, Kase,C.S.,et al, 1990